Navigation Links
Pelvalon Announces Results from the LIFE Pivotal Trial at the 2014 AUGS/IUGA Conference
Date:7/23/2014

SUNNYVALE, Calif., July 23, 2014 /PRNewswire/ -- Pelvalon, Inc. is making its clinical debut at the 2014 AUGS/IUGA Scientific Meeting in Washington, D.C. with the presentation of results from LIFE, a pivotal study of the Pelvalon's Vaginal Bowel Control (VBC) System.  Holly E. Richter, Ph.D, M.D., Director of the Division of Urogynecology and Pelvic Reconstructive Surgery at the University of Alabama at Birmingham and immediate Past President of the Society for Gynecological Surgeons (SGS), served as the National Principal Investigator and will be presenting the results at 11:55am on Thursday, July 24, 2014.

The LIFE study followed 61 women who used the VBC system.  At the 1-month primary endpoint, 79% of patients in the intent-to-treat cohort experienced treatment success (86% of patients in the per protocol cohort).  Risks were demonstrated to be very low, with zero device-related serious adverse events observed.  Additionally, 96% of the women who completed the trial found the insert to be comfortable, and 98% said they would recommend it to a friend.  "These results indicate that VBC may allow women to achieve a high degree of continence without risk of significant side effects and with an element of patient control," stated Dr. Richter. "This trial heralds a new era of treatment opportunity for women with bowel control problems."

Pelvalon's VBC System is the first to restore bowel control using a device placed in the vagina.  "Our goal is to provide a front-line therapy that poses minimal risk but delivers superior bowel control," said Pelvalon CEO Miles Rosen. "Today, women frequently don't report their symptoms.  We hope our technology will encourage patients and physicians to start a new dialogue about bowel control."

Over 20 million U.S. women suffer from loss of bowel control, also referred to as Fecal Incontinence (FI) or Accidental Bowel Leakage (ABL).  FI particularly affects women who have experienced pregnancy, childbirth, or nerve or muscle damage in the pelvic region.  Many women suffer in silence, fearing accidents and restricting their daily activities, because of the embarrassing stigma around the condition and the lack of successful, non-invasive treatments. 

About Vaginal Bowel Control
Restoring bowel control through the vagina is a new concept.  The VBC Insert is placed in the same location as a tampon.  The user inflates a balloon on the insert, which is designed to occlude the rectum to protect against unwanted stool passage.  Women can remove the insert at any time.  The VBC System is intended to offer women a non-invasive and non-surgical treatment option. 

The VBC System is limited by federal law to investigational use only and is not available for sale.

About Pelvalon
Headquartered in Sunnyvale, California, privately-held Pelvalon aims to change the lives of women who suffer from bowel control problems. Founded in 2010, Pelvalon's ground-breaking technology originated from Stanford University's Biodesign program, a collaboration between the schools of medicine and engineering.  Pevalon's investors include Norwich Ventures, a specialized venture capital firm focused on medtech.


'/>"/>
SOURCE Pelvalon
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
2. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
3. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
4. Misonix Announces New Distribution Agreement For Panama
5. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
6. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
7. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
8. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
9. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
10. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
11. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... 27, 2017 FinancialBuzz.com News Commentary  ... Based on New Frontier Data,s ... where cannabis is legal will generate $655 million in taxes on ... cannabis specific taxes, such as Washington State,s ... earned from state sales taxes that are applied on all retail ...
(Date:3/27/2017)... March 27, 2017 BioLineRx Ltd. (NASDAQ/TASE: ... announced today that AGI-134, an immunotherapy for the treatment of ... Ltd., will be featured at the upcoming American Association ... Washington, DC to be held on April 1-5, ... ...
(Date:3/27/2017)... 2017   Pulmatrix, Inc . (NASDAQ: PULM), a clinical ... pulmonary diseases, today announced that it has added two experts ... asthma to its Scientific Advisory Board . ... B. Moss , MD, former chief of the Pediatric Pulmonary ... Center at Stanford University, and David ...
Breaking Medicine Technology:
(Date:3/27/2017)... Cranbury, NJ (PRWEB) , ... March 27, 2017 ... ... publication of cutting-edge news, research and conference coverage on veterinary medicine, announces the ... The inaugural issue will be packaged with the April edition of American Veterinarian™. ...
(Date:3/27/2017)... Farmingdale, NY (PRWEB) , ... March 27, 2017 ... ... specializing in epigenetic research products enables researchers to pursue the recent RNA methylation ... RNA methylation . In light of the newfound characteristics of N6-methyladenosine, or ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... According to ... prostate cancer, including all stages, is more than 95%. Once the cancer spreads to ... less than 30%. To find out how to avoid this latter group, tune in ...
(Date:3/27/2017)... ... March 27, 2017 , ... ?Grow Healthy Vending LLC announced ... litigation between itself and 1800 Vending DBA Healthy You Vending. (Civil No. 1:14-CV-00121-CW/ ... to announce that we have now reached a settlement agreement regarding the ongoing ...
(Date:3/27/2017)... ... March 27, 2017 , ... Harris Communications, Inc., a leading provider of ... latest products to the Deaf Seniors of America Conference, April 4-7 at the Hotel ... with knowledgeable ASL friendly staff from Harris Communications and to try out the newest ...
Breaking Medicine News(10 mins):